Page 9 - COPD - Training Manual - Module 4

The percentage of healthy participants who could use the inhaler device without
errors (after reading just the patient instruction leaflet) at both visits was
significantly higher with Synchrobreathe® versus a pMDI. Lesser amount of time
was required to perform the inhalation technique correctly for Synchrobreathe®
than the pMDI.

Synchrobreathe® use resulted in fewer errors compared with the pMDI.

Importantly, the average time (in seconds) required to perform the inhalation
technique correctly for Synchrobreathe® during the first and second visit was
lesser than time taken for the pMDI, and all the di erences between visits 1 and 2
were significant (p<0.0001).

Overall, in the patient feedback (n=421), Synchrobreathe® was preferred over a
pMDI by a greater percentage of patients (Figure 21).

Figure 21: Comparison for evaluating preference, satisfaction
and choice of inhaler with Synchrobreathe® versus pMDI

The study also showed that Synchrobreathe® was easy to use. Overall, 92% of
patients found “Synchrobreathe® an easy-to-use device”, 88.5% patients said
“steps of Synchrobreathe® are easy to understand”, and 88% patients opined that
“Synchrobreathe® was easy to learn” (Figure 22).